Eli Lilly develops treatments for diabetes, obesity, and oncology. Mounjaro/Zepbound (GLP-1 drugs) are driving massive revenue growth in the obesity market.
Eli Lilly develops treatments for diabetes, obesity, and oncology. Mounjaro/Zepbound (GLP-1 drugs) are driving massive revenue growth in the obesity market.